CIK 2003159
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 36.50% | 5 |
| Equity Real Estate Investment Trusts (REITs) | 35.41% | 2 |
| Real Estate Management & Development | 28.09% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CBRE | CBRE GROUP, INC. | Real Estate | 28.09% |
| 2 | ADC | AGREE REALTY CORP | Real Estate | 27.34% |
| 3 | ARVN | ARVINAS, INC. | Health Care | 12.58% |
| 4 | ABVX | Abivax S.A. | Health Care | 10.40% |
| 5 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Care | 8.95% |
| 6 | WPC | W. P. Carey Inc. | Real Estate | 8.07% |
| 7 | ATAI | AtaiBeckley Inc. | Health Care | 4.06% |
| 8 | GRML | Greenland Mines Ltd | Health Care | 0.51% |
8/8 names classified · sector 100.0% of weight · industry 100.0% · mkt cap 89.6%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 100.0% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 55.4% of book weight (2/8 names) · unclassified 44.6%: ARVN, ABVX, MRVI, WPC, ATAI, GRML. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CBRECBRE GROUP INC | 49,817 | $7M | 28.1% | NEW |
| 2 | ADCAGREE RLTY CORP | 87,127 | $7M | 27.3% | NEW |
| 3 | ARVNARVINAS INC | 285,076 | $3M | 12.6% | ADD 71% |
| 4 | ABVXABIVAX SA | 22,428 | $2M | 10.4% | ADD 56% |
| 5 | MRVIMARAVAI LIFESCIENCES HLDGS I | 759,743 | $2M | 9.0% | ADD 66% |
| 6 | WPCW. P. Carey Inc. | 28,508 | $2M | 8.1% | NEW |
| 7 | ATAIATAIBECKLEY INC | 275,409 | $974,948 | 4.1% | NEW |
| 8 | GRMLKLOTHO NEUROSCIENCES INC | 370,049 | $122,116 | 0.5% | TRIM −39% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CBRECBRE GROUP INC | — | — | — | — | — | 50K | $7M |
| ADCAGREE RLTY CORP | — | — | — | — | — | 87K | $7M |
| ARVNARVINAS INC | — | — | — | — | 166K | 285K | $3M |
| ABVXABIVAX SA | — | — | — | — | 14K | 22K | $2M |
| MRVIMARAVAI LIFESCIENCES HLDGS I | — | — | — | — | 458K | 760K | $2M |
| WPCW. P. Carey Inc. | — | — | — | — | — | 29K | $2M |
| ATAIATAIBECKLEY INC | — | — | — | — | — | 275K | $974,948 |
| GRMLKLOTHO NEUROSCIENCES INC | — | — | — | — | 607K | 370K | $122,116 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
